Target Interacting Protein Information
Target General Information | |||||
---|---|---|---|---|---|
Target ID | T58921 | Target Info | |||
Target Name | Peroxisome proliferator-activated receptor gamma (PPAR-gamma) | ||||
Synonyms | PPAR-gamma; Nuclear receptor subfamily 1 group C member 3; NR1C3 | ||||
Target Type | Successful Target | ||||
Gene Name | PPARG | ||||
Biochemical Class | Nuclear hormone receptor | ||||
UniProt ID | |||||
Target Interacting Proteins | |||||
Acyltransferases | [+] 5 Acyltransferases | + | |||
Interacting Target Name | Histone acetyltransferase p300 (EP300) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Protein propionyltransferase p300; p300 HAT; P300; Histone crotonyltransferase p300; Histone butyryltransferase p300; E1A-associated protein p300; E1Aassociated protein p300 | ||||
Evidence Score (E-score) | 5 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [1] | |||
2 | Fluorescence Resonance Energy Transfer | [2] | |||
3 | Protein-peptide | [3] | |||
4 | Reconstituted Complex | [1] | |||
5 | Yeast two hybrid | [1] | |||
Interacting Protein Name | Nuclear receptor coactivator 1 (NCOA1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | F.SRC.1; KAT13A; RIP160; SRC1; bHLHe42; bHLHe74 | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Fluorescence Resonance Energy Transfer | [2] | |||
2 | Protein-peptide | [3] | |||
3 | Reconstituted Complex | [4] | |||
4 | Yeast two hybrid | [5] | |||
Interacting Target Name | Nuclear receptor coactivator 3 (NCOA3) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | TRAM-1; TRAM1; Thyroid hormone receptor activator molecule 1; Steroid receptor coactivator protein 3; SRC-3; Receptor-associated coactivator 3; RAC-3; RAC3; PCIP; NCoA-3; Class E basic helix-loop-helix protein 42; CBP-interacting protein; bHLHe42; Amplified in breast cancer-1 protein; Amplified in breast cancer 1 protein; AIB1 (SRC-3); AIB-1; AIB1; ACTR | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Fluorescence Resonance Energy Transfer | [2] | |||
2 | Protein-peptide | [3] | |||
3 | Reconstituted Complex | [4] | |||
Interacting Target Name | Tripartite motif-containing 24 (TRIM24) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Tripartite motif-containing protein 24; Transcription intermediary factor 1-alpha; TIF1-alpha; TIF1A; TIF1; RNF82; RING-type E3 ubiquitin transferase TIF1-alpha; RING finger protein 82; E3 ubiquitin-protein ligase TRIM24 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Fluorescence Resonance Energy Transfer | [2] | |||
2 | Protein-peptide | [6] | |||
Interacting Protein Name | Histone acetyltransferase KAT5 (KAT5) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | ESA1; HTATIP; HTATIP1; PLIP; TIP; TIP60; ZC2HC5; cPLA2 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Protein-peptide | [6] | |||
2 | Reconstituted Complex | [7] | |||
Auxiliary transporters | [+] 1 Auxiliary transporters | + | |||
Interacting Target Name | Caveolin 1 (CAV1) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Caveolin-1; Caveolin1; Cav-1; CAV | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [8] | |||
2 | Co-fractionation | [8] | |||
3 | Co-localization | [8] | |||
4 | Yeast two hybrid | [8] | |||
Carbon-nitrogen hydrolases | [+] 2 Carbon-nitrogen hydrolases | + | |||
Interacting Target Name | Histone deacetylase 4 (HDAC4) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | KIAA0288; HD4 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [9] | |||
2 | Reconstituted Complex | [10] | |||
Interacting Target Name | Histone deacetylase 3 (HDAC3) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | SMAP45; RPD3-2; RPD32; HD3 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [11] | |||
2 | Reconstituted Complex | [10] | |||
Kinases | [+] 2 Kinases | + | |||
Interacting Target Name | ERK activator kinase 1 (MEK1) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | PRKMK1; MKK1; Mitogen-activated protein kinase kinase 1; MEK 1; MAPKK 1; MAPK/ERKkinase 1; MAPK/ERK kinase 1; MAP kinase kinase 1; Dual specificity mitogen-activated protein kinase kinase 1 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [8] | |||
2 | Co-fractionation | [8] | |||
3 | Reconstituted Complex | [12] | |||
Interacting Target Name | Cyclin-dependent kinase 5 (CDK5) | Patented-recorded Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | TPKII catalytic subunit; Tau protein kinase II catalytic subunit; Serine/threonine-protein kinase PSSALRE; Serine/threonine protein kinase PSSALRE; Proline-directed protein kinase F(A) (PDPK F(A)); Proline-directed protein kinase 33 kDa subunit; PDPK; Cyclin-dependent-like kinase 5; Cyclin-dependent kinase 5 (CDK5); Cell division protein kinase 5; CDKN5 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [13] | |||
2 | Biochemical Activity | [14] | |||
Mediator complexes | [+] 1 Mediator complexes | + | |||
Interacting Protein Name | Mediator of RNA polymerase II transcription subunit 1 (MED1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | CRSP1; CRSP200; DRIP205; DRIP230; PBP; PPARBP; PPARGBP; RB18A; TRAP220; TRIP2 | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Fluorescence Resonance Energy Transfer | [2] | |||
2 | Protein-peptide | [3] | |||
3 | Reconstituted Complex | [4] | |||
4 | Yeast two hybrid | [15] | |||
Nuclear hormone receptors | [+] 4 Nuclear hormone receptors | + | |||
Interacting Target Name | Retinoic acid receptor RXR-alpha (RXRA) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | RXRalpha; Retinoid X receptor alpha; Nuclear receptor subfamily 2 group B member 1; NR2B1 | ||||
Evidence Score (E-score) | 6 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [16] | |||
2 | Affinity Capture-Western | [17] | |||
3 | Co-crystal Structure | [18] | |||
4 | Co-localization | [19] | |||
5 | Reconstituted Complex | [20] | |||
6 | Yeast two hybrid | [21] | |||
Interacting Target Name | Orphan nuclear receptor SHP (NR0B2) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Small heterodimer partner; SHP; Short heterodimer partner; Nuclear receptor subfamily 0 group B member 2 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [22] | |||
2 | Protein-peptide | [3] | |||
3 | Reconstituted Complex | [22] | |||
Interacting Target Name | Retinoic acid receptor RXR-beta (RXRB) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Retinoid X receptor beta; Nuclear receptor subfamily 2 group B member 2; NR2B2 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [16] | |||
2 | Affinity Capture-Western | [23] | |||
Interacting Target Name | Orphan nuclear receptor DAX-1 (NR0B1) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Nuclear receptor subfamily 0 group B member 1; Nuclear receptor DAX-1; DSS-AHC critical region on the X chromosome protein 1; DAX1; AHC | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Protein-peptide | [3] | |||
2 | Reconstituted Complex | [24] | |||
Oxidoreductases | [+] 1 Oxidoreductases | + | |||
Interacting Protein Name | Probable JmjC domain-containing histone demethylation protein 2C (JMJD1C) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | TRIP8 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Fluorescence Resonance Energy Transfer | [2] | |||
2 | Protein-peptide | [3] | |||
Transcription regulators | [+] 10 Transcription regulators | + | |||
Interacting Protein Name | Nuclear receptor corepressor 1 (NCOR1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | N.CoR; N.CoR1; PPP1R109; TRAC1; hN.CoR | ||||
Evidence Score (E-score) | 6 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [19] | |||
2 | Co-localization | [25] | |||
3 | Fluorescence Resonance Energy Transfer | [26] | |||
4 | Protein-peptide | [3] | |||
5 | Reconstituted Complex | [27] | |||
6 | Yeast two hybrid | [13] | |||
Interacting Protein Name | Nuclear receptor corepressor 2 (NCOR2) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | CTG26; N.CoR2; SMAP270; SMRT; SMRTE; SMRTE.tau; TNRC14; TRAC; TRAC.1; TRAC1 | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [19] | |||
2 | Co-localization | [25] | |||
3 | Protein-peptide | [3] | |||
4 | Yeast two hybrid | [21] | |||
Interacting Protein Name | PPAR-gamma coactivator 1-alpha (PPARGC1A) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | LEM6; PGC.1(alpha); PGC.1v; PGC1; PGC1A; PPARGC1 | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [28] | |||
2 | Protein-peptide | [3] | |||
3 | Reconstituted Complex | [29] | |||
4 | Yeast two hybrid | [15] | |||
Interacting Protein Name | Transcription factor p65 (RELA) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | NFKB3; p65 | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [30] | |||
2 | Biochemical Activity | [31] | |||
3 | Reconstituted Complex | [30] | |||
4 | Yeast two hybrid | [32] | |||
Interacting Target Name | CREB-binding protein (CREBBP) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | CREBbinding protein; CBP | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Protein-peptide | [3] | |||
2 | Reconstituted Complex | [33] | |||
3 | Yeast two hybrid | [34] | |||
Interacting Protein Name | Nuclear receptor coactivator 2 (NCOA2) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | GRIP1; KAT13C; NCoA.2; SRC2; TIF2; bHLHe75 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Fluorescence Resonance Energy Transfer | [2] | |||
2 | Protein-peptide | [3] | |||
3 | Yeast two hybrid | [15] | |||
Interacting Target Name | Transcription factor Sp1 (SP1) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | TSFP1 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [35] | |||
2 | Reconstituted Complex | [36] | |||
Interacting Target Name | CCAAT/enhancer binding protein beta (CEBPB) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Transcription factor CCAAT/enhancer-binding protein beta; Transcription factor 5; TCF-5; TCF5; PP9092; Nuclear factor NF-IL6; Liver-enriched inhibitory protein; Liver activator protein; LIP; LAP; CCAAT/enhancer-binding protein beta; C/EBP beta | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [37] | |||
2 | Reconstituted Complex | [36] | |||
Interacting Target Name | High mobility group protein HMG-I/Y (HMGA1) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | HMGIY; HMG-I(Y); High mobility group protein R; High mobility group protein HMG-I/HMG-Y; High mobility group protein A1; High mobility group AT-hook protein 1 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Reconstituted Complex | [36] | |||
2 | Yeast two hybrid | [38] | |||
Interacting Protein Name | Activating signal cointegrator 1 (TRIP4) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | ASC.1; ASC1; HsT17391; ZC2HC5 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Fluorescence Resonance Energy Transfer | [2] | |||
2 | Protein-peptide | [3] | |||
Other proteins | [+] 5 Other proteins | + | |||
Interacting Target Name | Nuclear receptor coactivator 4 (NCOA4) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | RFG; Ret-activating protein ELE1; Nuclear receptor coactivator 4; NCoA-4; ELE1; ARA70 (dARA70N); ARA70; Androgen receptor-associated protein of 70 kDa; Androgen receptor coactivator 70 kDa protein; 70 kDa AR-activator; 70 kDa androgen receptor coactivator | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Protein-peptide | [6] | |||
2 | Reconstituted Complex | [5] | |||
3 | Yeast two hybrid | [5] | |||
Interacting Protein Name | Nuclear receptor-interacting protein 1 (NRIP1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | RIP140 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Fluorescence Resonance Energy Transfer | [2] | |||
2 | Protein-peptide | [3] | |||
3 | Reconstituted Complex | [39] | |||
Interacting Protein Name | Zinc finger HIT domain-containing protein 3 (ZNHIT3) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | TRIP3 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Fluorescence Resonance Energy Transfer | [2] | |||
2 | Protein-peptide | [3] | |||
3 | Reconstituted Complex | [3] | |||
Interacting Protein Name | Glutamate receptor-interacting protein 1 (GRIP1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | GRIP | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Reconstituted Complex | [4] | |||
2 | Yeast two hybrid | [40] | |||
Interacting Protein Name | Nuclear receptor coactivator 6 (NCOA6) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | AIB3; ASC2; NRC; PRIP; RAP250; TRBP | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [41] | |||
2 | Protein-peptide | [3] | |||
References | |||||
REF 1 | p300 interacts with the N- and C-terminal part of PPARgamma2 in a ligand-independent and -dependent manner, respectively. J Biol Chem. 1999 Mar 19;274(12):7681-8. | ||||
REF 2 | Multiplexed molecular interactions of nuclear receptors using fluorescent microspheres. Cytometry. 2001 Aug 1;44(4):326-37. | ||||
REF 3 | Nuclear receptor-coregulator interaction profiling identifies TRIP3 as a novel peroxisome proliferator-activated receptor gamma cofactor. Mol Cell Proteomics. 2009 Oct;8(10):2212-26. | ||||
REF 4 | Discrete roles for peroxisome proliferator-activated receptor gamma and retinoid X receptor in recruiting nuclear receptor coactivators. Mol Cell Biol. 2000 Nov;20(21):8008-17. | ||||
REF 5 | Identification of ARA70 as a ligand-enhanced coactivator for the peroxisome proliferator-activated receptor gamma. J Biol Chem. 1999 Jun 4;274(23):16147-52. | ||||
REF 6 | T0070907, a selective ligand for peroxisome proliferator-activated receptor gamma, functions as an antagonist of biochemical and cellular activities. J Biol Chem. 2002 May 31;277(22):19649-57. | ||||
REF 7 | The adipogenic acetyltransferase Tip60 targets activation function 1 of peroxisome proliferator-activated receptor gamma. Endocrinology. 2008 Apr;149(4):1840-9. | ||||
REF 8 | The Ras inhibitors caveolin-1 and docking protein 1 activate peroxisome proliferator-activated receptor through spatial relocalization at helix 7 of its ligand-binding domain. Mol Cell Biol. 2011 Aug;31(16):3497-510. | ||||
REF 9 | Peroxisome proliferator-activated receptor is inhibited by histone deacetylase 4 in cortical neurons under oxidative stress. J Neurochem. 2011 Aug;118(3):429-39. | ||||
REF 10 | Interaction of nuclear receptor zinc finger DNA binding domains with histone deacetylase. Mol Cell Endocrinol. 2003 Aug 29;206(1-2):1-12. | ||||
REF 11 | The retinoblastoma-histone deacetylase 3 complex inhibits PPARgamma and adipocyte differentiation. Dev Cell. 2002 Dec;3(6):903-10. | ||||
REF 12 | Interaction with MEK causes nuclear export and downregulation of peroxisome proliferator-activated receptor gamma. Mol Cell Biol. 2007 Feb;27(3):803-17. | ||||
REF 13 | Adipocyte NCoR knockout decreases PPAR phosphorylation and enhances PPAR activity and insulin sensitivity. Cell. 2011 Nov 11;147(4):815-26. | ||||
REF 14 | GQ-16, a novel peroxisome proliferator-activated receptor (PPAR) ligand, promotes insulin sensitization without weight gain. J Biol Chem. 2012 Aug 10;287(33):28169-79. | ||||
REF 15 | A new class of peroxisome proliferator-activated receptor gamma (PPARgamma) agonists that inhibit growth of breast cancer cells: 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes. Mol Cancer Ther. 2004 Mar;3(3):247-60. | ||||
REF 16 | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. Mol Syst Biol. 2015 Jan 21;11(1):775. | ||||
REF 17 | Peroxisome proliferator-activated receptor gamma and retinoid X receptor transcription factors are released from activated human platelets and shed in microparticles. Thromb Haemost. 2008 Jan;99(1):86-95. | ||||
REF 18 | Structure of the intact PPAR-gamma-RXR- nuclear receptor complex on DNA. Nature. 2008 Nov 20;456(7220):350-6. | ||||
REF 19 | Epigenetic regulation of MicroRNA-122 by peroxisome proliferator activated receptor-gamma and hepatitis b virus X protein in hepatocellular carcinoma cells. Hepatology. 2013 Nov;58(5):1681-92. | ||||
REF 20 | PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell. 1998 Apr 17;93(2):241-52. | ||||
REF 21 | A selective peroxisome proliferator-activated receptor-gamma modulator, telmisartan, binds to the receptor in a different fashion from thiazolidinediones. Endocrinology. 2009 Feb;150(2):862-70. | ||||
REF 22 | Small heterodimer partner, an orphan nuclear receptor, augments peroxisome proliferator-activated receptor gamma transactivation. J Biol Chem. 2002 Jan 11;277(2):1586-92. | ||||
REF 23 | Peroxisome proliferator-activated receptors modulate proliferation and angiogenesis in human endometrial carcinoma. Mol Cancer Res. 2012 Mar;10(3):441-53. | ||||
REF 24 | The orphan nuclear receptor DAX-1 acts as a novel transcriptional corepressor of PPARgamma. Biochem Biophys Res Commun. 2008 May 30;370(2):264-8. | ||||
REF 25 | Corepressors selectively control the transcriptional activity of PPARgamma in adipocytes. Genes Dev. 2005 Feb 15;19(4):453-61. | ||||
REF 26 | The endocrine disruptor monoethyl-hexyl-phthalate is a selective peroxisome proliferator-activated receptor gamma modulator that promotes adipogenesis. J Biol Chem. 2007 Jun 29;282(26):19152-66. | ||||
REF 27 | Nuclear receptor corepressor-dependent repression of peroxisome-proliferator-activated receptor delta-mediated transactivation. Biochem J. 2002 Apr 1;363(Pt 1):157-65. | ||||
REF 28 | Hepatitis C virus NS5A protein increases hepatic lipid accumulation via induction of activation and expression of PPARgamma. FEBS Lett. 2009 Sep 3;583(17):2720-6. | ||||
REF 29 | Coordination of p300-mediated chromatin remodeling and TRAP/mediator function through coactivator PGC-1alpha. Mol Cell. 2003 Nov;12(5):1137-49. | ||||
REF 30 | Phosphorylation of PPARgamma via active ERK1/2 leads to its physical association with p65 and inhibition of NF-kappabeta. J Cell Biochem. 2003 Nov 1;90(4):732-44. | ||||
REF 31 | PPAR is an E3 ligase that induces the degradation of NFB/p65. Nat Commun. 2012;3:1300. | ||||
REF 32 | Hypoxia downregulates PPAR via an ERK1/2-NF-B-Nox4-dependent mechanism in human pulmonary artery smooth muscle cells. Free Radic Biol Med. 2013 Oct;63:151-60. | ||||
REF 33 | Peroxisome proliferator-activated receptor gamma-dependent repression of the inducible nitric oxide synthase gene. Mol Cell Biol. 2000 Jul;20(13):4699-707. | ||||
REF 34 | A yeast two-hybrid technology-based system for the discovery of PPARgamma agonist and antagonist. Anal Biochem. 2004 Dec 15;335(2):253-9. | ||||
REF 35 | Transcription of human resistin gene involves an interaction of Sp1 with peroxisome proliferator-activating receptor gamma (PPARgamma). PLoS One. 2010 Mar 29;5(3):e9912. | ||||
REF 36 | The insulin receptor: a new anticancer target for peroxisome proliferator-activated receptor-gamma (PPARgamma) and thiazolidinedione-PPARgamma agonists. Endocr Relat Cancer. 2008 Mar;15(1):325-35. | ||||
REF 37 | Inhibition of adhesive interaction between multiple myeloma and bone marrow stromal cells by PPARgamma cross talk with NF-kappaB and C/EBP. Blood. 2007 Dec 15;110(13):4373-84. | ||||
REF 38 | Retinoid-dependent recruitment of a histone H1 displacement activity by retinoic acid receptor. J Biol Chem. 1999 Aug 6;274(32):22563-8. | ||||
REF 39 | A regulatory role for RIP140 in nuclear receptor activation. Mol Endocrinol. 1998 Jun;12(6):864-81. | ||||
REF 40 | S 26948: a new specific peroxisome proliferator activated receptor gamma modulator with potent antidiabetes and antiatherogenic effects. Diabetes. 2007 Nov;56(11):2797-808. | ||||
REF 41 | H3K4 mono- and di-methyltransferase MLL4 is required for enhancer activation during cell differentiation. Elife. 2013 Dec 24;2:e01503. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Wang and Dr. Li.